CHICAGO, Ill. – November 29, 2015 – The GE Health Cloud[1] was unveiled today at the 101st annual Radiological Society of North America (RSNA) meeting in Chicago. Designed exclusively for the healthcare industry, the new cloud ecosystem and its applications will connect radiologists and clinicians to speed, efficiency and collaboration across care pathways and multidisciplinary... Read more
SAN ANTONIO, TEXAS – October 19, 2015 – GE Healthcare, a division of General Electric Company (NYSE: GE), is introducing the DiscoveryTM RT*, a new advanced radiation therapy planning computed tomography (CT) system at the 57th Annual American Society for Radiation Oncology (ASTRO) Meeting in San Antonio, Texas. http://www.genewsroom.com/press-releases/discovery-rt-designed-improve-accuracy-radiation-therapy-planning-282063 Read more
MENLO PARK, Calif., 2015-10-03 02:39 CEST (GLOBE NEWSWIRE) — A Pacific Biosciences of California, Inc. (NASDAQ:PACB), pioneira e líder em sequenciamento de leitura de longa duração usando sua tecnologia Single Molecule, Real-Time (Molécula Única, em Tempo Real – SMRT(R)), anunciou hoje que lançou uma nova plataforma de sequenciamento de ácido nucleico. O sistema Sequel(TM) proporciona... Read more
MENLO PARK, California, 2015-10-02 23:23 CEST (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB, pionera y líder en secuenciación de lecturas largas que utiliza tecnología de una sola molécula en tiempo real (Single Molecule, Real-Time, SMRT(R)), anunció hoy el lanzamiento de una nueva plataforma de secuenciación de ácidos nucleicos.El Sequel(TM)System ofrece un rendimiento y... Read more
New York City, NY – September 23, 2015 – GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop high-value, low-cost technologies and healthcare delivery solutions across multiple care settings. http://www.genewsroom.com/press-releases/ge-healthcare-announces-300-million-commitment-support-emerging-market-health-281784 Read more
GE Healthcare (NYSE:GE) is pleased to announce that the US Drug Enforcement Administration (DEA) has removed the compound ioflupane I 123 from the schedules of the Controlled Substance Act, which has resulted in the descheduling of DaTscan™ (Ioflupane I 123 Injection). http://www.genewsroom.com/press-releases/ge-healthcare-commends-dea-decision-will-make-datscan%E2%84%A2-ioflupane-i-123-injection-more Read more
BARRINGTON, Ill., July 30, 2015 — Following a medical scan, the time it takes for a patient’s medical images to be shared with his or her doctor and receive a diagnosis can vary from one hour to a few weeks. In today’s digital world, where people can share images with the touch of a button,... Read more
CHALFONT ST. GILES, UK, AND WAUKESHA, WI, USA – 29 July 2015 – In developed countries like the U.S., Europe and parts of Asia, healthcare leaders are trying to optimize efficiency, systems integration, data analytics and achieve greater productivity. In emerging economies, enabling access to affordable, basic primary care is often the most pressing concern.... Read more
Summary: http://www.genewsroom.com/press-releases/now-playing-4d-your-heart-281214 Read more
Poznan, June 24, 2015. – Affidea today held a celebration to mark the inauguration of a new and innovative GE Healthcare PET-CT scanner at the company’s diagnostic facility in the Medical Center Hospital of Poznan, Poland. http://www.genewsroom.com/press-releases/affidea-installs-innovative-ge-healthcare-pet-ct-scanner-poznan-poland-281184 Read more